Combination treatments effectively mitigated colonic shortening, reduced neutrophil infiltration (measured via MPO activity) and normalised spleen weight in both acute and chronic colitis models (Figure 3 and Figure 4). The gene discussed is MPO; the disease is Chronic colitis.